Brought to you by:
Prognostic tool for CVO stenting set to enhance therapeutic decision-making and scientific reporting
With the aims of predicting and comparing venous stent outcomes, aiding in communication with patients, and enhancing therapeutic decision-making, researchers have proposed an anatomical classification system for patients with chronic venous obstruction (CVO) of the iliofemoral tract undergoing interventional procedures.…
New analysis details learning curve effect behind ‘significant improvement’ in performance of PE mechanical thrombectomy over time
A multisite hospital system analysis of the safety and procedural learning curve behind the performance of percutaneous mechanical thrombectomy for pulmonary embolism (PE) shows significant reductions in both fluoroscopy and procedure times alongside contrast volume over time. The data, the…
Shape Memory Medical announces first European enrolment in AAA-SHAPE pivotal trial
Shape Memory Medical today announced the first European enrollment in the AAA-SHAPE pivotal trial, the company’s prospective, multicenter, randomized, open-label trial to determine the safety and effectiveness of the Impede-FX RapidFill device to improve abdominal aortic aneurysm (AAA) sac behavior…
Stryker completes acquisition of Inari Medical
Stryker announced today that it has completed the acquisition of Inari Medical. A press release notes that the addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing venous thromboembolism (VTE) segment. “The acquisition of Inari…
Study demonstrates textbook outcomes occur less than a quarter of the time after CLTI revascularization
Textbook outcomes remain “very rare” after revascularization for chronic limb-threatening ischemia (CLTI), with the main driver being an enduring inability to attain complete wound healing and to return patients to their preoperative ambulatory status, according to the lead researcher behind…
Countdown to New Orleans: VAM 2025 set to explore innovation
The 2025 Vascular Annual Meeting (VAM) will take place in New Orleans, Louisiana, from June 4–7, with a particular focus this year on innovation. Key program highlights coming up this year include case-based learning sessions entitled “Optimal Management of the…
BEST-CLI trial spline model analysis breaks new ground in assessing the impact of CKD severity on CLTI outcomes
A new analysis of the BEST-CLI trial has produced the first evidence-based glomerular filtration rate (eGFR) value—30 mL m2—as the cutoff below which patients with chronic limb-threatening ischemia (CLTI) experience significantly worse outcomes after revascularization regardless of the treatment modality…
Deep vein arterialization: Much remains to be learned but use poised to expand in patients with less severe ischemia
These remain early days for transcatheter arterialization of the deep veins (TADV) in the setting of patients with severe chronic limb-threatening ischemia (CLTI), says Daniel Clair, MD, one of the principal investigators in key clinical trials of the procedure, but…
InspireMD and NAMSA to partner on CGUARDIANS II pivotal clinical trial
InspireMD and North American Science Associates (NAMSA) today announced that, pursuant to a previously announced strategic outsourcing partnership, the companies are working together to conduct the CGUARDIANS II pivotal study of InspireMD’s CGuard Prime 80cm carotid stent system for use in…
Akura Medical enrols first patient in QUADRA-PE study
Akura Medical has announced today the first patient enrolment in the QUADRA-PE study evaluating the Katana thrombectomy system in patients with acute pulmonary embolism (PE). The initial procedure was successfully performed by Samuel Horr, director of cardiovascular research at TriStar Centennial…